Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $194,632 - $215,221
-4,362 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $19,211 - $24,912
-394 Reduced 8.28%
4,362 $227,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $19,868 - $22,410
-360 Reduced 7.04%
4,756 $295,000
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $1.77 Million - $2.21 Million
-35,087 Reduced 87.27%
5,116 $283,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $37,989 - $43,733
-634 Reduced 1.55%
40,203 $2.54 Million
Q4 2017

Feb 09, 2018

SELL
$59.94 - $65.35 $179 - $196
-3 Reduced 0.01%
40,837 $2.5 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $43,852 - $50,609
-794 Reduced 1.91%
40,840 $2.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
41,634
41,634 $2.32 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ns Partners LTD Portfolio

Follow Ns Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ns Partners LTD with notifications on news.